Published in N Engl J Med on August 05, 1999
Sex, Aging and Antiretroviral Pharmacokinetics | NCT00666055
Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One (2010) 10.39
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses (2001) 6.00
The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health (2001) 5.32
Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2010) 2.25
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Ann Intern Med (2015) 2.13
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 2.11
Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV. PLoS One (2015) 2.02
Factors associated with delayed initiation of HIV medical care among infected persons attending a southern HIV/AIDS clinic. South Med J (2006) 1.88
Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol (2002) 1.82
Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial. J Acquir Immune Defic Syndr (2008) 1.70
Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS (2011) 1.66
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J Virol (2004) 1.49
Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol (2003) 1.42
Testing for HIV infection in pregnancy. Paediatr Child Health (2008) 1.38
Operational effectiveness of single-dose nevirapine in preventing mother-to-child transmission of HIV. Bull World Health Organ (2007) 1.34
Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol (2007) 1.19
HIV-prevention science at a crossroads: advances in reducing sexual risk. Curr Opin HIV AIDS (2009) 1.18
Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden. J Clin Microbiol (2007) 1.15
Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study. J Acquir Immune Defic Syndr (2010) 1.14
Mother-to-child transmission of HIV in a community-based antiretroviral clinic in South Africa. S Afr Med J (2010) 1.13
Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. AIDS Res Ther (2015) 1.08
Awareness and attitudes about HIV among pregnant women in Aksu, northwest China. Open AIDS J (2008) 1.08
Morbidity and mortality among infants born to HIV-infected women in South Africa: implications for child health in resource-limited settings. J Trop Pediatr (2010) 1.08
HIV treatment as prevention: the key to an AIDS-free generation. J Food Drug Anal (2013) 1.05
Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women. BMC Pediatr (2012) 1.04
Immunology of pediatric HIV infection. Immunol Rev (2013) 1.02
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Med (2008) 0.99
Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? Proc Natl Acad Sci U S A (2002) 0.99
Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity. AIDS Res Hum Retroviruses (2012) 0.96
The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol (2003) 0.95
The role of cell-associated virus in mother-to-child HIV transmission. J Infect Dis (2014) 0.95
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy). BMC Public Health (2011) 0.95
The cost-effectiveness of directly observed highly-active antiretroviral therapy in the third trimester in HIV-infected pregnant women. PLoS One (2010) 0.94
Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants. BMC Infect Dis (2008) 0.91
Risk factors associated with false positive HIV test results in a low-risk urban obstetric population. J Pregnancy (2011) 0.91
Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin. PLoS One (2013) 0.91
The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90
A Study of Effects of MultiCollinearity in the Multivariable Analysis. Int J Appl Sci Technol (2014) 0.88
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1. Am J Trop Med Hyg (2009) 0.87
Cost-effectiveness of a package of interventions for expedited antiretroviral therapy initiation during pregnancy in Cape Town, South Africa. AIDS Behav (2014) 0.86
Fetal immune activation to malaria antigens enhances susceptibility to in vitro HIV infection in cord blood mononuclear cells. J Infect Dis (2010) 0.86
The breadth and titer of maternal HIV-1-specific heterologous neutralizing antibodies are not associated with a lower rate of mother-to-child transmission of HIV-1. J Virol (2012) 0.85
Missed connections: HIV-infected people never in care. Public Health Rep (2013) 0.85
A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS Res Ther (2008) 0.85
Testing for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy. Paediatr Child Health (2001) 0.84
Advances and failures in preventing perinatal human immunodeficiency virus infection. Clin Microbiol Rev (2009) 0.82
Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission. Clin Perinatol (2010) 0.82
The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy. J Int AIDS Soc (2013) 0.81
Perinatal Transmission of HIV: Recognition and Treatment Interventions. Curr Infect Dis Rep (2001) 0.80
A randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancy. AIDS Patient Care STDS (2013) 0.80
Mother-to-infant transmission of HIV-1: the placenta fights back. J Clin Invest (2001) 0.79
A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City. Clin Infect Dis (2014) 0.79
Maternal viral load and the risk of perinatal transmission of HIV-1. N Engl J Med (1999) 0.79
Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study. J Acquir Immune Defic Syndr (2016) 0.79
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy. Clin Infect Dis (2013) 0.79
Reducing the risk of maternal-infant transmission of HIV by attacking the virus. N Engl J Med (1999) 0.79
German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res (2009) 0.78
HIV and Pregnancy in Resource-Poor Settings. Rev Obstet Gynecol (2010) 0.77
Fetal allostimulation of maternal cells: a potential mechanism for perinatal HIV transmission following obstetrical hemorrhage. AIDS Res Hum Retroviruses (2008) 0.77
Persistent genital tract HIV-1 RNA shedding after change in treatment regimens in antiretroviral-experienced women with detectable plasma viral load. J Womens Health (Larchmt) (2013) 0.77
Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clin Diagn Lab Immunol (2005) 0.77
Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1. AIDS Res Hum Retroviruses (2016) 0.77
The necessity of HIV testing in Iranian pregnant women and its ethical considerations. J Med Ethics Hist Med (2009) 0.75
Care of HIV-infected pregnant women in maternal-fetal medicine programs. Infect Dis Obstet Gynecol (2001) 0.75
UK national clinical audit: management of pregnancies in women with HIV. BMC Infect Dis (2017) 0.75
Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study. Virulence (2016) 0.75
HIV-1 Nef breaches placental barrier in rat model. PLoS One (2012) 0.75
Care of the HIV-infected pregnant woman in the developed world. Obstet Med (2015) 0.75
Recent advances: Paediatrics. BMJ (2001) 0.75
Complications of cesarean deliveries among HIV-infected women in the United States. AIDS (2014) 0.75
Comorbidity measures for use with administrative data. Med Care (1998) 46.67
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA (2000) 10.17
Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med (1999) 5.05
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories. J Clin Microbiol (1996) 4.81
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet (1999) 4.61
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med (2001) 4.26
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr (1966) 3.52
Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol (1999) 3.18
Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med (1991) 3.02
Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1. J Immunol (1982) 2.90
A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med (1992) 2.81
Early T lymphocytes. Differentiation in vivo of adult intrathymic precursor cells. J Exp Med (1985) 2.81
Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (1986) 2.64
Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase. J Clin Microbiol (1999) 2.63
Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med (1993) 2.58
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS (2000) 2.49
Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev (2000) 2.38
Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings. Lancet (2003) 2.38
Outcome of pregnancy in a woman with an increased body mass index. BJOG (2005) 2.38
Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS) Hepatology (2000) 2.30
An Lyt differentiated thymocyte subpopulation detected by flow microfluorometry. Nature (1979) 2.29
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis (1994) 2.26
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS (1999) 2.23
Knowledge of HIV/AIDS transmission and screening in United States blood donors. Transfusion (2001) 2.20
Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med (1996) 2.08
The potential impact of incentives on future blood donation behavior. Transfusion (2001) 2.05
Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr (1996) 2.02
XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. J Immunol (1979) 2.02
Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA (1998) 2.00
Evaluation of a home-based intervention program to reduce infant passive smoking and lower respiratory illness. J Behav Med (1994) 1.97
Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA (1997) 1.91
Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice. J Exp Med (1978) 1.89
Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85
Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras. J Immunol (1981) 1.85
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Immunologic responses in malnourished children. Am J Clin Nutr (1975) 1.78
Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol (1993) 1.78
Cell surface antigen expression on thymocytes: development and phenotypic differentiation of intrathymic subsets. Immunol Rev (1984) 1.75
Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics (1977) 1.70
A cell cycle-specific requirement for the XRCC1 BRCT II domain during mammalian DNA strand break repair. Mol Cell Biol (2000) 1.69
The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen. J Exp Med (1976) 1.67
Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65
Absence of an antigen-specific helper T cell required for the expression of the T 15 idiotype in mice treated with anti-mu antibody. Eur J Immunol (1980) 1.62
Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol (2003) 1.62
The H-2 phenotype of the thymus dictates the self-specificity expressed by thymic but not splenic cytotoxic T lymphocyte precursors in thymus-engrafted nude mice. J Immunol (1981) 1.60
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS (1996) 1.59
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
The magnitude and duration of itch produced by intracutaneous injections of histamine. Somatosens Res (1987) 1.55
Relationship between dideoxyinosine exposure, CD4 counts, and p24 antigen levels in human immunodeficiency virus infection. A phase I trial. Ann Intern Med (1992) 1.55
Geographic mobility and children's emotional/behavioral adjustment and school functioning. Pediatrics (1994) 1.53
Spontaneous abortion and general illness symptoms among semiconductor manufacturers. J Occup Med (1988) 1.52
Cognitive performance predicts treatment decisional abilities in mild to moderate dementia. Neurology (2006) 1.50
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation. J Pediatr (1974) 1.48
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. J Infect Dis (1998) 1.47
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion (2003) 1.47
School achievement and absence in children with chronic health conditions. J Pediatr (1985) 1.46
Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics (1975) 1.45
Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst (1989) 1.44
Standard and special human immune serum globulins as therapeutic agents. Pediatrics (1979) 1.44
Characteristics of BALB/C T cell lymphomas grown as continuous in vitro lines. J Immunol (1978) 1.42
Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J Epidemiol Community Health (2002) 1.42
Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics (2000) 1.42
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med (1984) 1.41
Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr (2001) 1.41
Interlaboratory concordance of DNA sequence analysis to detect reverse transcriptase mutations in HIV-1 proviral DNA. ACTG Sequencing Working Group. AIDS Clinical Trials Group. J Virol Methods (1998) 1.41
Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature (1986) 1.39
Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N Engl J Med (1969) 1.39
Clinical and immunologic features of dysgammaglobulinemia type I. Report of a case diagnosed in the first year of life. Am J Med (1966) 1.39
Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India. Indian J Med Res (2007) 1.39
Prevention of platelet alloimmunization. Transfusion (1991) 1.38
Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy. J Clin Invest (2001) 1.38
Child care arrangements and repeated ear infections in young children. Am J Public Health (1993) 1.38